BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bukhari MA, Al-Theaby A, Tawhari M, Al-Shaggag A, Pyrke R, Gangji A, Treleaven D, Ribic C. Efficacy and safety of non-vitamin K antagonist oral anticoagulants post-kidney transplantation. World J Transplant 2019; 9(6): 134-144 [PMID: 31750090 DOI: 10.5500/wjt.v9.i6.134] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Parker K, Chu J, Morton M, Bhutani S, Picton M, Mitra S, Thachil J. Can direct oral anticoagulants be used in kidney transplant recipients? Clin Transplant 2021;:e14474. [PMID: 34498777 DOI: 10.1111/ctr.14474] [Reference Citation Analysis]
2 Kotecha S, Ivulich S, Snell G. Review: immunosuppression for the lung transplant patient. J Thorac Dis 2021;13:6628-44. [PMID: 34992841 DOI: 10.21037/jtd-2021-11] [Reference Citation Analysis]
3 Stöllberger C, Finsterer J. Update on drug interactions with non-vitamin-K-antagonist oral anticoagulants for stroke prevention in elderly patients. Expert Rev Clin Pharmacol 2021;14:569-81. [PMID: 33757376 DOI: 10.1080/17512433.2021.1908124] [Reference Citation Analysis]
4 Pfrepper C, Herber A, Weimann A, Siegemund R, Engelmann C, Aehling N, Seehofer D, Berg T, Petros S. Safety and efficacy of direct oral anticoagulants under long-term immunosuppressive therapy after liver, kidney and pancreas transplantation. Transpl Int 2021;34:423-35. [PMID: 33336411 DOI: 10.1111/tri.13804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Batarfi A, Alenezi H, Alshehri A, Balelah S, Kazim H, Algthami M, Hussain MM, Alshehri N, Alsharif R, Ashour H, Althobaiti M, Alotaibi S, Steinmetz H, Foerch C. Patient-guided modifications of oral anticoagulant drug intake during Ramadan fasting: a multicenter cross-sectional study. J Thromb Thrombolysis 2021;51:485-93. [PMID: 32666427 DOI: 10.1007/s11239-020-02218-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Zaitoun MF, Sheikh ME, Faifi ASA, Mahedy AW, Nazer WE, El Hennawy HM. The Use of Non-Vitamin K Antagonist Oral Anticoagulants in Post-Kidney Transplantation, Single-Center Experience. Transplant Proc 2021:S0041-1345(21)00738-7. [PMID: 34772494 DOI: 10.1016/j.transproceed.2021.09.042] [Reference Citation Analysis]
7 Bixby AL, Lichvar AB, Salerno D, Park JM. Use of direct-acting oral anticoagulants in solid organ transplantation: A systematic review. Pharmacotherapy 2021;41:28-43. [PMID: 33155327 DOI: 10.1002/phar.2485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Basic-Jukic N, Furic-Cunko V, Juric I. Novel Oral Anticoagulants in Renal Transplant Recipients: A Retrospective Cohort Study. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2020;41:49-55. [PMID: 33011699 DOI: 10.2478/prilozi-2020-0032] [Reference Citation Analysis]